Hofheim, Germany

Norbert Krass

This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2003.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Norbert Krass: Innovator in Hyperlipidemia Treatment

Introduction

Norbert Krass is a notable inventor based in Hofheim, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of hyperlipidemia. His innovative work has led to the development of a patent that addresses this important health issue.

Latest Patents

Norbert Krass holds a patent for the "Use of bissulfonamides for producing medicines for the treatment of hyperlipidemia." This patent highlights his commitment to advancing medical treatments and improving patient outcomes.

Career Highlights

Krass is currently employed at Aventis Pharma Deutschland GmbH, where he continues to work on innovative solutions in the pharmaceutical industry. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Throughout his career, Norbert has worked alongside esteemed colleagues such as Reinhard Kirsch and Hans-Ludwig Schaefer. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Norbert Krass is a dedicated inventor whose work in the treatment of hyperlipidemia has made a significant impact in the medical field. His patent and ongoing contributions at Aventis Pharma Deutschland GmbH exemplify his commitment to innovation and improving health outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…